World’s First AI-designed Immuno-oncology Drug to Enter Clinical Trials
Exscientia, a leading artificial intelligence (AI) driven pharmatech company based in Oxford, England, announced that the first AI-designed molecule for
Read moreExscientia, a leading artificial intelligence (AI) driven pharmatech company based in Oxford, England, announced that the first AI-designed molecule for
Read moreThe National Institute for Health and Care Excellence (NICE) has recommended carfilzomib in combination with lenalidomide and dexamethasone (KRd) for
Read moreThe unique 3DProSeed® ready-to-use 96-well microtiter plate developed by Ectica Technologies contains pre-assembled synthetic hydrogels, ready for screening 3D cell
Read moreAgilent Technologies Inc., an American analytical instrumentation manufacturing company, announced it has entered into a definitive agreement to acquire Resolution
Read moreAmgen and Five Prime Therapeutics, a clinical-stage biotech corporation focusing on discovering immuno-oncology and personalized cancer treatments, announced on the
Read moreThe cutting-edge multispectral tissue cytometry hardware TissueFAXS SPECTRA, developed by TissueGnostics, has the unique ability to enable multispectral imaging of
Read moreThe modern brightfield and fluorescence scanning system by TissueGnostics offers unparalleled flexibility for researchers working on tissue-based cell culture analysis
Read moreTissueGnostics has launched a new cutting-edge compact digital brightfield slide scanner with remote real-time viewing and live stitching modes combined
Read moreRoche has revealed that their assay Elecsys® GDF-15 assay has been approved as a companion diagnostic (CDx) in cancer therapy
Read moreThe next-gen TissueFAXS Q confocal imaging systems are highly flexible scanning platforms which offer the advantages of both laser-free ultra-fast
Read more